Literature DB >> 1089842

Cytoplasmic contractile apparatus in aortic endothelial cells of hypertensive rats.

G Gabbiani, M C Badonnel, G Rona.   

Abstract

Hypertension was produced in male Wistar rats (150 gm. body weight) by complete ligature of the aorta between the renal arteries. Electron microscopic examination revealed that 1 week later the amount of cytoplasmic microfilaments in the endothelial cells of the aortic segment above the coarctation (mean blood pressure 160 mm. Hg) was strikingly increased as compared with normal animals. The endothelial cells in the segment below the coarctation (mean blood pressure 25 mm. Hg) contained few filaments and were similar to the cells in the aortic endothelium in controls (mean blood pressure 105 mm. Hg). Microfilaments measured 40 to 70 angstrom in diameter and were mostly located close to the endothelial clefts, where they formed longitudinal bundles or a network. The bundles of microfilaments contained electron-dense areas similar to the "attachment sites" of the underlying smooth muscle. By using en face preparations of aortic endothelial cells treated with antiactin autoantibodies (AAA) followed by anti-human IgG, it was seen that in hypertensive animals the cells above the ligature were intensely fluorescent when compared with those of the aortic portion below the ligature or those of the controls. The fluorescence was abolished after incubation of the AAA sera with thrombosthenin A. The correlation between electron microscopic and immunologic findings suggests that the microfilaments present in the endothelial cells of hypertensive animals are composed, at least in part, of actin. Endothelial cells so modified may play a role in permeability or may be related to other phenomena such as electrotonic coupling and synchronized contraction of aortic cells during hypertension.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1089842

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  23 in total

1.  Three-dimensional changes of the cytoskeleton of vascular endothelial cells exposed to sustained hydrostatic pressure.

Authors:  S A Salwen; D H Szarowski; J N Turner; R Bizios
Journal:  Med Biol Eng Comput       Date:  1998-07       Impact factor: 2.602

2.  Decreased vascular reactions to permeability factors in experimental diabetes.

Authors:  M A Llorach; G M Böhm; J G Leme
Journal:  Br J Exp Pathol       Date:  1976-12

3.  Contractile events during inflammation.

Authors:  G Gabbiani; M C Badonnel
Journal:  Agents Actions       Date:  1976-02

4.  The actin filament bundling protein α-actinin-4 actually suppresses actin stress fibers by permitting actin turnover.

Authors:  James Peter Kemp; William M Brieher
Journal:  J Biol Chem       Date:  2018-07-26       Impact factor: 5.157

5.  Ultrastructural and permeability characteristics of retinal vessels in stroke-prone spontaneously hypertensive rats.

Authors:  W L Lin; E Essner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

6.  Electron microscopy of the plexiform lesion.

Authors:  P Smith; D Heath
Journal:  Thorax       Date:  1979-04       Impact factor: 9.139

7.  Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages.

Authors:  R G Gerrity; H K Naito; M Richardson; C J Schwartz
Journal:  Am J Pathol       Date:  1979-06       Impact factor: 4.307

8.  Morphologic and functional changes of the aortic intima during experimental hypertension.

Authors:  G Gabbiani; G Elemer; C Guelpa; M B Vallotton; M C Badonnel; I Hüttner
Journal:  Am J Pathol       Date:  1979-08       Impact factor: 4.307

9.  Actin, myosin, and laminin localization in retinal vessels of the rat.

Authors:  S R Gordon; E Essner
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

10.  Influence of diabetes on the reactivity of mesenteric microvessels to histamine, bradykinin and acetylcholine.

Authors:  Z B Fortes; J Garcia Leme; R Scivoletto
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.